What is ENGAGe? Who is ENGAGe? And what do we do?
|
|
- Samson Lamb
- 6 years ago
- Views:
Transcription
1 What is ENGAGe? Who is ENGAGe? And what do we do? ENGAGe Executive Committee Murat Gultekin (Co-Chair, Clinicien) Esra Urkmez (Co-Chair, Patient Advocacy) Birthe Lemley (Denmark) Michaela Simona Ene (Romania) Elisabeth Avall Lundqvist (Sweden) Rene Laky (Austria) Cristiana Sessa (Switzerland)
2 1
3 Achievements We Run, We Spin Against Cancer, We organize yearly Patient Seminars Fact Sheets for Patients, Patient recommendations, Guidelines: Fact Sheets for Patients What is Cervical Cancer (English, Spanish) - updated 2017 What is Ovarian Cancer (English, Spanish, Swedish) - updated 2017 What is Uterine Cancer (English) What is a Clinical Trial (English, Spanish, Swedish) Gynecological Cancers in Europe Facts Sheets What is Vulvar Cancer - to be done from a scratch ESGO Patient recommendations and Guidelines Patient friendly version of different materials developed by ESGO for professionals will be designed to assist patients and their families
4 TITLE OF THE STUDY: ENGAGe Patient Survey 2017 in Europe - What patients want to tell their doctors? OBJECTIVE : From the mouth of patients, tell their doctors and heath care providers: What is being done good by their Health Care Team, What is missing in patient care and what areas need improvements? TIMING: Data collection was in field during August and September of LOCATION: SAMPLE: METHOD: The survey was conducted and finalized across Czech Republic, Denmark, Germany, Great Britain, Greece, Hungary, Poland, Serbia, Spain and Turkey. The target group was Gynecologic Cancer Patients from 10 European Countries. Total of 1436 surveys were collected thru ENGAGe network. Survey has been translated into countries mother languages The survey was carried out as online web interviewing (CAWI) and as pdf in person format: it used a structured questionnaire (10 demographic + 25 question on awareness, prevention, diagnosis, treatment, clinical trial and conclusion) prepared by ENGAGe Team, reviewed by Executive Team, volunteer doctors and Non Profit Organization Members within ENGAGe network. 3
5 Special Thanks to our SPONSORS: Priviledged Educational Partner Supporter
6 AND to the TEAM who made it happen: Murat Gultekin ENGAGe CO-Chair, Renata Brandtnerova - Executive Director, ESGO Office David Cibula, ESGO President ENGAGe Committee Murat Gultekin (Co-Chair, Clinicien) Esra Urkmez (Co-Chair, Patient Advocate) Birthe Lemley (Denmark) Michaela Simona Ene (Romania) Elisabeth Avall Lundqvist (Sweden) Rene Laky (Austria) Cristiana Sessa (Switzerland) ESGO Prag Team - especially Lucie Lamlova, Quintiles IMS Team Martin Vadura, Jiří Krýza Elif Andac Jones, Research Consultant and Political Sociologist at Georgetown University Luzia Travado, IPOS Board of Directors William S. Breitbart, Chair -Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering 5
7 AND to the Patient Organizations and our Volunteer Doctors who distributed the survey thru online and in pdf form: Country Doctor / Patient Organization Country Doctor / Patient Organization Czech Republic Poland David Cibula Doctor Kamil Zalewski Doctor & Blue Butterfly foundation Veronika Cibulova Volunteer Serbia Michael Halaska Doctor Vesna Bondzic Women's Center Milica, Kraljevo Public Health institute Daniel Driak Doctor Spain Denmark Lucas Minig Doctor Birhte Lemley KIU Cristina Zorrero Doctor Germany Turkey Jalid Sehouli Stiftung Eierstock Krebs Muzaffer Sanci Doctor Susanne Fechner Stiftung Eierstock Krebs Murat Alan Doctor Jacek Grabowski Doctor Sevil Benli Kanserle Dans Association Gulhan Inci Doctor Asli Ortakmac Kanser Savascilari Greece UK Maria Papageorgiu K.E.F.I. of Athens Christina Fotopoulou Doctor Hungary Jonathan Ledermann Doctor Ildiko Nagy-Toth Mallow Flower Foundation Ross Little Ovarian Cancer Action 6
8 Number of respondents by country total Czech Republic (CZE) Denmark (DNK) Germany (DEU) Great Britain (GBR) Greece (GRC) Hungary (HUN) Poland (POL) Serbia (SCG) Spain (ESP) Turkey (TUR) 7
9 Current health condition SORTED BY YEAR OF DIAGNOSIS 0% 20% 40% 60% 80% 100% TOTAL (N=1436) 12.9% 18.7% 26.2% 33.6% Currently under treatment (N=535) 7.7% 13.6% 20.2% 54.6% I have finished treatment (N=739) 6.4% 16.6% 21.0% 28.8% 21.8% I have relapsed (N=162) 5.6% 13.0% 24.7% 34.0% 18.5% up to year
10 What type of cancer do you have? SORTED BY COUNTRY 0% 20% 40% 60% 80% 100% TOTAL (N=1436) 39.3% 26.3% 15.3% 12.9% CZE (N=173) 41.0% 28.3% 19.1% DNK (N=125) 45.6% 33.6% 15.2% DEU (N=119) 74.8% 6.7% 12.6% GBR (N=231) 76.2% 6.5% 7.4% GRC (N=108) 11.1% 70.4% 7.4% 10.2% HUN (N=123) 76.4% 18.7% POL (N=110) 31.8% 15.5% 20.0% 20.0% 7.3% SCG (N=152) 9.2% 74.3% 10.5% ESP (N=113) 75.2% 13.3% 7.1% TUR (N=182) 11.5% 65.4% 15.9% 6.0% Ovarian cancer Breast cancer Uterine cancer Cervical cancer Fallopian tube cancer Vulval cancer Vaginal cancer 9
11 5.2% 2.4% 16.8% 13.9% 9.3% 19.1% 20.4% 27.5% 16.4% 16.8% 17.8% 24.4% 30.7% 32.4% 44.5% 37.6% 38.7% 41.2% 39.9% 37.8% 33.2% 24.3% 39.2% 31.1% 33.8% 42.6% 24.1% 19.8% 26.4% 23.6% 30.9% 35.5% 33.5% 32.8% 29.2% 33.0% 40.3% 37.4% 48.0% 47.8% 45.5% 48.1% 43.4% 46.1% 56.5% 55.5% 55.8% 63.2% 62.4% 70.9% 69.9% 81.5% 82.1% 82.9% AWARENESS - Knowledge of screenings/methods Have you heard of any of the following screenings or methods that might help prevent these gynaecological cancers? SORTED BY COUNTRY The most frequently mentioned graphed multiple choice question 100.0% 80.0% 60.0% 40.0% 20.0% 0.0% PAP smear for Cervical Carcinoma HPV vaccine for Cervical Carcinoma HPV test for Cervical Carcinoma BRCA Tests for Ovarian Carcinoma none of above mentioned TOTAL (N=1436) CZE (N=173) DNK (N=125) DEU (N=119) GBR (N=231) GRC (N=108) HUN (N=123) POL (N=110) SCG (N=152) ESP (N=113) TUR (N=182) 10
12 PREVENTION Which of the following screening tests do you regularly attend? SORTED BY COUNTRY 0% 20% 40% 60% 80% 100% TOTAL (N=1436) 32.7% 27.6% 24.9% 14.8% CZE (N=173) 17.3% 36.4% 34.7% 11.6% DNK (N=125) 52.8% 7.2% 12.8% 27.2% DEU (N=119) 38.7% 33.6% 23.5% GBR (N=231) 32.9% 8.2% 36.8% 22.1% GRC (N=108) 58.3% 10.2% 14.8% 16.7% HUN (N=123) 61.0% 22.8% 15.4% POL (N=110) 16.4% 44.5% 26.4% 12.7% SCG (N=152) 13.2% 63.2% 15.1% 8.6% ESP (N=113) 15.9% 45.1% 30.1% 8.8% TUR (N=182) 31.9% 31.3% 21.4% 15.4% cervical and breast cancer never followed routine cervical nor breast cancer screenings breast cancer cervical cancer 11
13 SO US PATIENTS, WHAT DO WE WANT TO TELL OUR HEALTH CARE PROVIDERS? Many of us did not know about HPV vaccinations, PAP Smear Test, nor BRCA Tests for Ovarian Carcinoma - WE WANT TO KNOW, WE NEED TO BE EDUCATED Even if we knew, many of us did not attend as we had no access to them, or no finances to get them done, or we did not find them relevant to us. AGAIN, WE NEED TO BE EDUCATED, and WE NEED ACCESS TO THEM. We need to find a way on how we can improve the prevention in these countries, together. Don t forget, numbers and studies are meaningless unless we do something with them 12
14 DIAGNOSIS AND TREATMENT STAGE: First conversations, First shocking moments, First informative conversations with doctors A NEW LIFE FOR PATIENTS BEGINS 13
15 How would you describe your first conversation with your doctor/ nurse/ health care team? SORTED BY COUNTRY 0% 20% 40% 60% 80% 100% TOTAL (N=1436) 44.7% 29.7% 16.6% 9.1% CZE (N=173) 65.9% 19.7% 9.8% DNK (N=125) 35.2% 26.4% 34.4% DEU (N=119) 49.6% 39.5% 7.6% GBR (N=231) 37.7% 31.2% 17.3% 13.9% GRC (N=108) 50.0% 23.1% 22.2% HUN (N=123) 43.9% 34.1% 14.6% 7.3% POL (N=110) 32.7% 30.9% 20.0% 16.4% SCG (N=152) 36.2% 38.2% 11.8% 13.8% ESP (N=113) 50.4% 28.3% 10.6% 10.6% TUR (N=182) 45.1% 26.9% 22.0% very good and clear - described everything about my disease and treatment good but I was in too big of much shock to process the information good, but not clear - the information was not very clear very distant, and not clear- the language they used was not clear to me 6.0% 14
16 Did you received printed educational materials from your health care provider after your first conversation? SORTED BY COUNTRY 0% 20% 40% 60% 80% 100% TOTAL (N=1436) CZE (N=173) 68.9% 64.2% 31.1% 35.8% DNK (N=125) 37.6% 62.4% DEU (N=119) 72.3% 27.7% GBR (N=231) 47.2% 52.8% GRC (N=108) HUN (N=123) POL (N=110) SCG (N=152) ESP (N=113) TUR (N=182) 95.4% 86.2% 76.4% 83.6% 75.2% 72.5% 4.6% 13.8% 23.6% 16.4% 24.8% 27.5% no yes 15
17 Did you think these educational materials were helpful? SORTED BY COUNTRY 0% 20% 40% 60% 80% 100% TOTAL (N=446) CZE (N=62) DNK (N=78) DEU (N=33) GBR (N=122) 91.3% 95.2% 92.3% 87.9% 90.2% 8.7% 7.7% 12.1% 9.8% GRC (N=5) 60.0% 40.0% HUN (N=17) 100.0% POL (N=26) 76.9% 23.1% SCG (N=25) ESP (N=28) TUR (N=50) 96.0% 90.0% 100.0% 10.0% yes no 16
18 SO US PATIENTS, WHAT DO WE WANT TO TELL OUR DOCTORS WHO DIAGNOSE US FOR TREATMENT? Many of us did not get printed informative material from you during first visits and we were too shocked to understand what you were telling us WE WANT PRINTED MATERIALS TO TAKE HOME, SO WHEN WE GET OVER THE SHOCK WE CAN EDUCATE ORSELVES AND OUR CAREGIVERS AT HOME HOW: We need to find a way to work together to achieve this. Patient organizations should be working with doctors to provide the informative brochures, and we will need sponsors to do so. AGAIN Don t forget, numbers and studies are meaningless unless we do something with them 17
19 Waiting Time - How long did you have to wait before treatment started? 18
20 NOW, THE TREATMENT STARTS PATIENTS MOSTLY DON T KNOW: WHAT TO EXPECT WHAT TO EAT HOW TO COPE AND HOW TO LIVE WITH IT 19
21 4.0% 1.7% 7.5% 10.4% 9.0% 1.7% 5.6% 0.8% 4.5% 1.8% 3.3% 2.6% 1.8% 6.6% 8.1% 16.2% 12.6% 13.2% 8.7% 7.4% 10.5% 9.5% 7.4% 9.1% 17.1% 17.4% 15.4% 25.6% 21.9% 15.1% 21.2% 13.2% 26.1% 22.2% 23.6% 17.8% 16.8% 24.7% 24.0% 34.9% 31.6% 33.3% 25.9% 30.9% 22.7% 28.3% 35.2% 37.0% 41.8% 40.3% 44.6% 50.4% 48.4% 54.6% 64.7% Were you offered any complimentary help? If yes, which of followings: SORTED BY COUNTRY 80.0% 60.0% 40.0% 20.0% 0.0% psychological support information on existing diet recommendation / patient organizations or dietitian help support groups rehabilitation programme social support TOTAL (N=1436) CZE (N=173) DNK (N=125) DEU (N=119) GBR (N=231) GRC (N=108) HUN (N=123) POL (N=110) SCG (N=152) ESP (N=113) TUR (N=182) 20
22 Evaluations of Doctors and Nurses by Patients: How strongly do you agree or disagree with the following statements? 21
23 WHAT DO WE WANT TO TELL OUR DOCTORS: We are here We are a team: patients, caring families, patient organizations, doctors, nurses, other heath care professionals AND we SURELY want to do something with the numbers, with the results AND we want to improve the care of the patients together AND If you would like to be a part of our vision, ENGAGe needs your help! 22
REPORT. Patient Seminar. Held during The ESGO State of the Art Conference September 08-10, 2016 Antalya,Turkey
REPORT Patient Seminar Prevention in Gynaecological Malignancies September 08-09, 2016 Held during The ESGO State of the Art Conference September 08-10, 2016 Antalya,Turkey The European Voice of Gynaecological
More informationMENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa
MENTAL HEALTH CARE OECD HCQI Expert meeting 17 th of May, 2013 Rie Fujisawa Mental health indicators Any hospital readmissions for patients with schizophrenia Same hospital readmissions for patients with
More informationWhat is a clinical trial? An introduction for patients and families
What is a clinical trial? An introduction for patients and families Introduction Life expectancy in Europe in the first decade of this century has continued to rise. We owe this fortunate development to
More informationA Timely Decision A STORY ABOUT FACING BARRIERS IN ORDERTO PREVENT CERVICAL CANCER
A Timely Decision A STORY ABOUT FACING BARRIERS IN ORDERTO PREVENT CERVICAL CANCER STARRING MARY Prof. YAYA LOLI BLANCA JULIA 1 Mary, Loli y Julia are friends who meet during English classes held at a
More informationSmokefree Policies in Europe: Are we there yet?
Smokefree Policies in Europe: Are we there yet? 14 April 2015, 9:00 10:30am Rue de l Industrie 24, 1040 Brussels Permanent Partners: Temporary Partners: The research for the SFP Smokefree Map was partially
More informationNSGO Annual Meeting 2019
Nordic Society of Gynaecological Oncology NSGO Annual Meeting 2019 Radisson Blu Scandinavia Hotel Amager Blvd. 70, 2300 Copenhagen Theme: Advances in the Management of Gynaecological Cancer Patients 28
More informationWhere we stand in EFORT
Where we stand in EFORT Engaging with the new EU regulatory landscape for medical devices. Challenges & opportunities Brussel, Belgium April 6, 2018 Per Kjaersgaard-Andersen Associate Professor Section
More informationEngagement in language assessment / Regions of Europe
Summary table: Engagement in language / Regions of This table lists the statistically significant differences in the engagement in activities by the respondents from different s of : If the word or appears
More informationthe high CVD risk smoker
Smoking Cessation: population and patients A comprehensive approach to the smoker the high CVD risk smoker Catriona Jennings Cardiovascular Specialist Research Nurse Imperial College London European Society
More informationWhat women should know about. cervical cancer. American Cancer Society Guidelines for the Early Detection of Cervical Cancer
What women should know about cervical cancer American Cancer Society Guidelines for the Early Detection of Cervical Cancer One of the best things you can do so you don t get cervical cancer is get regular
More informationOverview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
More informationGuidance for Travelers on Temporary Work Assignment Abroad
infected person to immediately seek medical care but, prior to arrival, notify their healthcare provider that they may have been exposed to AI. For more information about avian influenza, see www.cdc.gov/flu/avian/facts.htm,
More informationEuropa Donna in Europe and in Slovenia
Europa Donna in Europe and in Slovenia Mojca Sencar EUROPA DONNA, The Slovenian Breast Cancer Association LJUBLJANA, SLOVENIA ED The European Breast Cancer Founded in 1994 Affiliates national forums from
More informationWorld Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006
World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006 WHO Regional Office for Europe Vaccine-preventable Diseases and Immunization programme,
More informationBreaking the silence: Sexual health impact on mental well-being
Breaking the silence: Sexual health impact on mental well-being The GAMIAN-Europe survey Table of content The Analyses 5 Background Characteristics 6 Mental Health & Treatment 9 Sexual Health Satisfaction
More informationSummary of Results for Laypersons
What was the Study Called? Summary of Results for Laypersons A Phase IIIb/IV Randomized, Controlled, Open-Label, Parallel Group Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration
More informationBiology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?
Biology Report Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium
More informationDetails of HPV-based Cervical Cancer Screening in Turkey
Details of HPV-based Cervical Cancer Screening in Turkey Murat Gultekin, MD, Assoc. Prof., Gyn Oncol Divison Cervical Cancer in Turkey Incidence: 4-5 /100.000 (Years 2004-2015) Annual New Cases: 1.800
More informationAldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato Urso, Niek Klazinga, Roberto Ferrari, Nikolaos Maniadakis and Luigi Tavazzi.
Appropriateness of prescriptions of recommended treatments in OECD health systems: findings based on the Long-Term Registry of the ESC on Heart Failure Aldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato
More informationCardiomyopathy and Myocarditis Registry. Newsletter N 16 October Dear Investigators,
Cardiomyopathy and Myocarditis Registry Newsletter N 16 October 2016 Page 1 Some words from the Chairman Dear Investigators, Page 2 to 4. - Study plan - Registry status - Some key variables Page 4 to 6
More informationEuropean Association of Dental Public Health Prevention of Oral Cancer
European Association of Dental Public Health Prevention of Oral Cancer Special Interest Working Group Thursday 14th November 2013 PD Dr. Katrin Hertrampf, MPH Dr. Colwyn Jones, Associate Editor Malta 2013
More informationProject Meeting Prague
Project Meeting Prague IO1 Assessment 9.11.217 CHRISTINA PADBERG ON BEHALF OF FRANKFURT UAS Current Status Assessment matrix was fully evaluated Experts have been interviewed, Interviews were fully evaluated
More informationThe Spanish Society of Medical Oncology: objectives, structure and history
The Spanish Society of Medical Oncology: objectives, structure and history The Spanish Society of Medical Oncology (SEOM) brings together Spanish specialists who are dedicated solely to fighting cancer
More informationRisk perception and food safety: where do European consumers stand today?
Risk perception and food safety: where do European consumers stand today? Lucia de Luca Press Officer, EFSA Outline Objective Methodology Risk perceptions Views on public authorities action Sources of
More informationOECD Family database OECD - Social Policy Division - Directorate of Employment, Labour and Social Affairs
SF.5: Childlessness Definitions and methodology The postponement of parenthood over the last decades, which can be gleaned from the declining percentage of childless women at different points over the
More informationOutcomes of Health Systems : Towards the development of indicators of amenable mortality
Outcomes of Health Systems : Towards the development of indicators of amenable mortality Work: Juan G. Gay Presentation: Valérie Paris OECD October 9, 2009 Objectives of the project Explore the potential
More informationCERVICAL CANCER FACTSHEET. What is cervical cancer?
CERVICAL CANCER FACTSHEET What is cervical cancer? ENGAGe is releasing a series of factsheets to raise awareness of gynaecological cancers and to support its network to work at a grassroots level. Take-up
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.12.2008 COM(2008) 882 final REPORT FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE
More informationWCPT COUNTRY PROFILE December 2017 HUNGARY
WCPT COUNTRY PROFILE December 2017 HUNGARY HUNGARY NUMBERS WCPT Members Practising physical therapists 727 Total number of physical therapist members in your member organisation 4,000 Total number of practising
More informationWCPT COUNTRY PROFILE December 2017 SERBIA
WCPT COUNTRY PROFILE December 2017 SERBIA SERBIA NUMBERS WCPT Members Practising physical therapists 622 Total number of physical therapist members in your member organisation 3,323 Total number of practising
More informationThe Asian American Women Empowered: Participant Interviews
The Asian American Women Empowered: Participant Interviews Project funded by: Orange County Asian and Pacific Islander Community Alliance Centers for Disease Control and Prevention Mt. Sinai Health Care
More informationWCPT COUNTRY PROFILE December 2017 SWEDEN
WCPT COUNTRY PROFILE December 2017 SWEDEN SWEDEN NUMBERS WCPT Members Practising physical therapists 11,043 Total number of physical therapist members in your member organisation 17,906 Total number of
More informationAlcohol-related harm in Europe and the WHO policy response
Alcohol-related harm in Europe and the WHO policy response Lars Moller Programme Manager World Health Organization Regional Office for Europe Date of presentation NCD global monitoring framework: alcohol-related
More informationIs there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?
Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis? Introduction Tuberculosis is a serious disease caused by the bacterium Mycobacterium tuberculosis.
More informationPrevention of Oral Cancer Special Interest Working Group
Prevention of Oral Cancer Special Interest Working Group Dr Colwyn Jones, Consultant in Dental Public Health, NHS Health Scotland, 1 South Gyle Crescent, Edinburgh EH12 9EB, Scotland. colwyn.jones@nhs.net
More informationOVARIAN CANCER FACTSHEET. What is ovarian cancer?
OVARIAN CANCER FACTSHEET What is ovarian cancer? ENGAGe is releasing a series of factsheets to raise awareness of gynaecological cancers and to support its network to work at grassroots level. Ovarian
More informationWe are here for our fellow patients
We are here for our fellow patients André Deschamps Boardmember EUOMO November 22, 2017 The European Prostate Cancer Coalition I am a prostate cancer survivor since 2003 Some facts on Europa Uomo The change
More informationRAISING THE AWARENESS OF GYNAECOLOGICAL CANCER. Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015.
RAISING THE AWARENESS OF GYNAECOLOGICAL CANCER Penny Bognuda CNS Gynaecologic Oncology ADHB. June 2015. AIMS AND OBJECTIVES OF THE NEXT ½ HOUR. Brief overview of the different types of gynaecological cancers
More informationBreast and Cervical Cancers in Barbados A Situational Analysis HEATHER ARMSTRONG MEDICAL OFFICER OF HEALTH, MINISTRY OF HEALTH, BARBADOS
Breast and Cervical Cancers in Barbados A Situational Analysis HEATHER ARMSTRONG MEDICAL OFFICER OF HEALTH, MINISTRY OF HEALTH, BARBADOS Contents Background Barbados Strategic Plan for the Prevention and
More informationA Cross Sectional Study on Knowledge, Attitude and Practice of Cervical Cancer Screening Among Women in Thiruvanmiyur, Chennai
A Cross Sectional Study on Knowledge, Attitude and Practice of Cervical Cancer Screening Among Women in Thiruvanmiyur, Chennai Sneha Sethumadhavan (1), Chitra. A (1) Abstract Aims: To assess the knowledge,
More informationScreening for Cervical Cancer in Europe
Asturias, 23 October, 2011 Asturias, 23 October Screening for Cervical Cancer in Europe M. Arbyn Unit Cancer Epidemiology, IPH, Brussels, Belgium Rue Juliette Wytsmanstraat 14 1050 Brussels Belgium T +32
More informationEuropean Collaboration on Dementia. Luxembourg, 13 December 2006
European Collaboration on Dementia Luxembourg, 13 December 2006 2005 Call for projects Special attention has also to be given to information and definition of indicators on neurodegenerative, neurodevelopment,
More informationCHRODIS Kick-off. Communication and Dissemination. Cristina Chiotan / Anna Gallinat Public Health Coordinator / Communications Assistant
CHRODIS Kick-off Communication and Dissemination Cristina Chiotan / Anna Gallinat Public Health Coordinator / Communications Assistant EuroHealthNet The European Partnership for improving health, equity
More informationENYGO REPORT. Summary
ENYGO REPORT Summary The first ENYGO Workshop on Fertility Sparing in Gynaecological Oncology was held at La Paz University Hospital in Madrid (Spain) from 27 to 28 January 2017. It was a very successful
More informationVaccinate or not vaccinate. Ingrid Hankes Drielsma 29 th PNAE meeting Naples
Vaccinate or not vaccinate Ingrid Hankes Drielsma 29 th PNAE meeting Naples Reason for giving thought to vaccinations in the Netherlands 2016 when the Paediatric nurses of the Dutch nursing organization
More informationNEW INSIGHTS IN RARE GYNAECOLOGICAL MALIGNANCIES OCTOBER 4-6, 2018 LYON, FRANCE LYON, FRANCE SPONSORSHIP PROSPECTUS
NEW INSIGHTS IN RARE GYNAECOLOGICAL MALIGNANCIES LYON, FRANCE SPONSORSHIP PROSPECTUS 02 NEW INSIGHTS IN RARE GYNAECOLOGICAL MALIGNANCIES NEW INSIGHTS IN RARE GYNAECOLOGICAL MALIGNANCIES 03 TABLE OF CONTENT
More informationThe health economic landscape of cancer in Europe
1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor
More informationMaking Connections: Early Detection Hearing and Intervention through the Medical Home Model Podcast Series
Making Connections: Early Detection Hearing and Intervention through the Medical Home Model Podcast Series Podcast 2 Utilization of the Teach-Back Methodology in Early Hearing Detection and Intervention
More informationEmerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018
Emerging Risks Mapping of Activities in Member States 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018 BACKGROUND 67 th Advisory Forum Meeting, Utrecht, The Netherlands, 6 February
More informationEnglish for living in the UK. The Cervical Smear
English for living in the UK The Cervical Smear At a glance... Objective This class is aimed at teaching new arrivals to the UK about the need for cervical screening and to reduce the anxiety a smear test
More informationFRIDAY NOON LECTURE SERIES
U54 Pilot Study (2015-2018) NIH/NCI Grant U54 143931 FRIDAY NOON LECTURE SERIES Aziza Lucas Wright, M.Ed. Instructor Charles R. Drew University of Medicine and Science Community Engagement Division College
More informationNational Survey of Teens and Young Adults on HIV/AIDS
Topline Kaiser Family Foundation National Survey of Teens and Young Adults on HIV/AIDS November 2012 This National Survey of Teens and Young Adults on HIV/AIDS was designed and analyzed by public opinion
More informationIOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President
IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos Jonathan Hughes IOSH Vice President About the Institution of Occupational Safety and Health (IOSH) www.iosh.co.uk
More informationThere are two supplemental tables presented here. The first, Table A.1, compares the items in the
Appendix There are two supplemental tables presented here. The first, Table A.1, compares the items in the modified Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS) to those included in the
More informationLong Term Forensic Psychiatric Care in the Netherlands. Peter Braun Pompestichting Nijmegen/Zeeland/Vught. 8th of November 2018
Long Term Forensic Psychiatric Care in the Netherlands 1920 s: law to admit dangerous mentally ill offenders into special hospitals after WW II: humane penal system Peter Braun Pompestichting Nijmegen/Zeeland/Vught
More informationREVIEW OF THE ANALYSIS RELATED TO RABIES DIAGNOSIS AND FOLLOW-UP OF ORAL VACCINATION PERFORMED IN NRLS IN 2015
European Union European Union WHO Collaborating OIE Reference Reference Centre Reference NANCY LABORATORY FOR RABIES AND WILDLIFE Laboratory for Rabies Institute for Rabies Serology for Research and Management
More informationPalliative nursing care of children and young people across Europe
Palliative nursing care of children and young people across Europe Results of a postal survey in August 2016 Updated in April 2017 (presented at the 29th PNAE-meeting in Naples/Italy on 28th April 2017)
More informationEUVAC.NET A surveillance network for vaccine-preventable diseases
EUVAC.NET A surveillance network for vaccine-preventable diseases Mark Muscat EUVAC.NET Co-ordinator Department of Epidemiology Statens Serum Institut Denmark Email: mmc@ssi.dk Viral Hepatitis Prevention
More information508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender
An overview of suicide statistics This document summarises information about suicide deaths in New Zealand covering up to 13. It does not attempt to explain causes of suicidal behaviour or causes of changes
More informationState of provision of Hearing Aids in Europe
Creating a barrier-free Europe for all hard of hearing citizens State of provision of Hearing Aids in Europe 2018 Report 1 Executive Summary Dear Reader, We are pleased to share the report examining affordability
More informationNSGO Annual Meeting 2019
Nordic Society of Gynaecological Oncology NSGO Annual Meeting 2019 Radisson Blu Scandinavia Hotel Amager Blvd. 70, 2300 Copenhagen Theme: Advances in the Management of Gynaecological Cancer Patients 27
More informationGynecologic Cancer French Hospital Medical Center Cancer Committee Public Report
Table of Contents: PAGE 1 Community Cancer Center Program at French Hospital Medical Center PAGE 2 Gynecologic Oncology Program on the Central Coast PAGE 3 Gynecologic Cancer Basic Facts and Risk Factors
More informationA study of afatinib compared with methotrexate in patients with cancer of the head and neck that has returned or spread
A study of afatinib compared with methotrexate in patients with cancer of the head and neck that has returned or spread This is a summary of a clinical study in patients with head and neck cancer. It is
More informationNote on the harmonisation of SILC and EHIS questions on health
EUROPEAN COMMISSION EUROSTAT Directorate F: Social statistics and Information Society Unit F-5: Health and food safety statistics 23/01/2008 Note on the harmonisation of SILC and EHIS questions on health
More informationPrevent You can prevent cancer of the cervix
Follow the PAP Strategy Plan Act Plan to have a Pap Test Make an appointment with your doctor Prevent You can prevent cancer of the cervix Learning Objectives To know what a Pap test is and why it is important
More informationCO-CHAIRS: Andrés Cervantes, Spain Jean-Yves Douillard, France
ESMO Preceptorship Programme Colorectal Cancer Multidisciplinary management, standards of care and future perspectives Prague, Czech Republic 6-7 July 2016 CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves
More informationPassport to Health Preventing and Recognizing Gynecologic Cancers
Passport to Health Preventing and Recognizing Gynecologic Cancers Presented by: Obstetrician/Gynecologist Leigh Bauer, M.D. They can sneak up on you. 2 Gynecologic cancers, that is. Knowing the facts can
More informationDevelopment of Palliative Care services in different countries
Development of Palliative Care services in different countries Nicoleta Mitrea EONS leadership summit, 2017 Disclosure speaker Do you have any interest to declare? No, I don t have any interest to declare.
More informationJoint Programming in Neurodegenerative Disease Research (JPND)
Joint Programming in Neurodegenerative Disease Research (JPND) Building Alliances and Collaborations Prof. Philippe Amouyel, MD, PhD JPND Chair France Disclosure CEO of Fondation Plan Alzheimer Conference
More informationPrimary and secondary prevention of sudden cardiac death in emerging economies
Primary and secondary prevention of sudden cardiac death in emerging economies Béla Merkely MD, PhD, DSc, FESC Heart Center Semmelweis University Budapest Common risk factors for sudden cardiac death Increasing
More informationQ1 What age are you?
Q1 What age are you? Answered: 504 Skipped: 0 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 4.56% 23 3.77% 19 4.56% 23 6.15% 31 3.97% 20 6.55% 33 5.95% 30 6.75% 34 6.35% 32 4.37% 22 6.75% 34 5.56%
More informationEuropean Dietetic Action Plan Progress report 2017
European Dietetic Action Plan Progress report 2017 Samantha Cushen, EFAD Project Manager Annemieke van Ginkel-Res,Honorary President 29 September 2018 EFAD The European Dietitians www.efad.org 1 EuDAP
More informationNSGO Annual Meeting 2019
Nordic Society of Gynaecological Oncology NSGO Annual Meeting 2019 Radisson Blu Scandinavia Hotel Amager Blvd. 70, 2300 Copenhagen Theme: Advances in the Management of Gynaecological Cancer Patients 27
More informationPARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information
PARALLELISM AND THE LEGITIMACY GAP 1 Appendix A Country Information PARALLELISM AND THE LEGITIMACY GAP 2 Table A.1 Sample size by country 2006 2008 2010 Austria 2405 2255 0 Belgium 1798 1760 1704 Bulgaria
More informationWomen s silent cancers The state of gynaecological cancers in Europe
Women s silent cancers The state of gynaecological cancers in Europe Contents Introduction... 3 Cervical cancer... 4 Ovarian cancer... 5 Vulval cancer... 6 Vaginal cancer... 7 Uterine cancer... 8 Fallopian
More informationWHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA
WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA September 2017 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe Marmorvej
More informationCross Border Genetic Testing for Rare Diseases
Cross Border Genetic Testing for Rare Diseases EUCERD Joint Action WP8 Helena Kääriäinen National Institute for Health an Welfare, Helsinki, Finland Starting point Possibilities and demand for genetic
More informationGETTING A GRIP. A Report Into Breast Health Understanding Among Women In Australia
GETTING A GRIP A Report Into Breast Health Understanding Among Women In Australia Based on independent research carried out by AMR for the McGrath Foundation October 2016 FOREWORD With the sheer number
More informationA report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%
% of reported measles cases WHO EpiBrief A report on the epidemiology of selected vaccine-preventable diseases in the European Region No. /17 This issue of WHO EpiBrief provides an overview of selected
More informationBarriers to cervical screening among year olds
Barriers to cervical screening among 25-29 year olds With cervical screening (smear test) uptake falling year on year, and one in three young women who are invited to their first cervical screening not
More informationeffective national MS societies strengthened our capacity to facilitate for the rights of people affected by MS. We have
MSIF s Annual Review 2007 Leading the Global MS Movement Cover image: Blue = countries in contact with MSIF Message from the chairman Sarah Phillips OBE, DL Chairman In this review you will see how far
More informationEuropean Status report on Alcohol and Health
European Status report on Alcohol and Health Dr Lars Moller Regional Advisor a.i. WHO Regional Office for Europe Main killers in the WHO European Region Source: Preventing chronic diseases. A vital investment.
More informationRECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON
RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE 2018 2019 WINTER SEASON October 2018 Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for
More informationFieldwork: February March 2010 Publication: October 2010
Special Eurobarometer 345 European Commission Mental Health Part 1: Report Fieldwork: February March 2010 Publication: October 2010 Special Eurobarometer 345 / Wave 73.2 TNS Opinion & Social This survey
More informationEUROPEAN GUIDE ON QUALITY IMPROVEMENT IN COMPREHENSIVE CANCER CONTROL
EUROPEAN GUIDE ON QUALITY IMPROVEMENT IN COMPREHENSIVE CANCER CONTROL Policy Paper on National Cancer Control Programmes (NCCPs)/ Cancer Documents in Europe Marjetka Jelenc, Tit Albreht, Karen Budewig,
More informationClinical Study Results
This is a summary of the main results of a clinical study for the drug lacosamide. UCB Biopharma SPRL sponsored this study and wants to share the results with the participants and the public. Thank you!
More informationSummary of Results for Laypersons
What was the Study Called? Summary of Results for Laypersons A Randomized, Double-blind, Parallel-group, Placebo- and Active-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability
More informationPrimary Palliative Care Task Force
Primary Palliative Care Research Group http://www.cphs.mvm.ed.ac.uk/groups/ppcrg/ Primary Palliative Care Task Force Update 4, Lancaster, Oct 2013 18 th to 22 Feb 13 International Primary Palliative Care
More informationWAPCEPC MEMBERSHIP SURVEY 2011
WAPCEPC MEMBERSHIP SURVEY 2011 Type of response Individual 231 94% Organization 14 6% Total 245 100% 1. RESPONSES INDIVIDUALS Current member of WAPCEPC? Yes 165* 74% No 60 26% Total 225 100% * Corresponds
More informationQuality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)
Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) Guidelines for Users May 2016 B1 Chorlton Mill, 3 Cambridge Street, Manchester, M1 5BY, UK Tel: +44 (0)161 226 4446 Fax: +44
More informationWHO International Radon Project: Rationale and current results
WHO International Radon Project: Rationale and current results Radiation and Environmental Health Programme Public Health and Environment Dept. Health Security and Environment Cluster Hajo Zeeb, University
More informationGlobal Patient Survey. Country-Specific Report Belgium
Global Patient Survey Country-Specific Report Belgium HCV Quest Country-Specific Report ABOUT HCV QUEST The biggest barrier I have faced in the fight against viral hepatitis is... no recognition, lack
More information